Orbimed Advisors - INOTEK PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2018$7,788,000
+8.0%
7,000,0000.0%0.09%
+9.3%
Q2 2018$7,214,000
+6.5%
7,000,0000.0%0.09%
+2.4%
Q1 2018$6,772,000
+14.4%
7,000,0000.0%0.08%
+12.0%
Q4 2017$5,918,000
+6.7%
7,000,0000.0%0.08%
+41.5%
Q3 2017$5,547,000
+30.2%
7,000,0000.0%0.05%
+17.8%
Q2 2017$4,261,000
-3.9%
7,000,0000.0%0.04%
-10.0%
Q1 2017$4,433,000
-39.7%
7,000,0000.0%0.05%
-46.8%
Q4 2016$7,354,000
-23.0%
7,000,0000.0%0.09%
-13.8%
Q3 2016$9,547,0007,000,0000.11%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders